Clinical Outcomes Following Surgical Debridement of Diabetic Foot Infection with Borderline Vascularity

Clinical Outcomes Following Surgical Debridement of Diabetic Foot Infection with Borderline Vascularity: an Important Consideration of Timing of Revascularization

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05553509

Enrollment

Registered

2022-09-23

Start date

2023-01-01

Completion date

2025-09-01

Last updated

2024-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Limb Threatening Ischemia

Brief summary

Observe Timing to complete healing of wounds & Limb salvage in both cohorts those who are undergoing Debridement only and those who are undergoing Debridement plus PTA

Detailed description

Secondary Aims of the study include Length of hospital stay , Necessity of further intervention(Whether a Revascularization Procedure or More Debridement sessions) , Incidence of MACE (Major Adverse Cardiovascular Events) in both groups

Interventions

OTHERPER CUTANEOUS TRANSLUMINAL ANGIOPLASTY

SURGICAL DEBRIDEMNT

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

30 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients will be included in this study are those suffering from DFUs; and Borderline Ischemia (BLI) / Borderline Vacularity with (Rutherford Grade I Categories 2&3) when they have a borderline ankle systolic pressure

Exclusion criteria

* All patients with (CLI) and DFUs as they are indicated for urgent re-vascularization. Severely infected/ gangrenous wounds requiring amputation hindering possible limb salvage. Lesions lying within or adjacent to an aneurysm; Non diabetic cases with foot ulcers; Arteritic lesions;(Vasculitic Patients). Patients had prior major amputation, bypass surgery, and endarterectomy on any vessel of the ipsilateral (target) extremity

Design outcomes

Primary

Measure	Time frame	Description
Clinical Outcomes Following Surgical Debridement of Diabetic Foot Infection With Borderline Vascularity	1 YEAR	1. Observe the timing to complete wound healing in both cohorts those with Debridement only & those with Debridment plus PTA 2. Observe the Rate of limb salvage in both groups

Secondary

Measure	Time frame	Description
Clinical Outcomes Following Surgical Debridement of Diabetic Foot Infection With Borderline Vascularity	1 YEAR	1-Observe incidence of MACE In both cohorts Observe necessity for further interventions in both cohorts 3-Observe the length of hospital stay in both groups

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026